Business Valuation

AVISTA is pleased to be the sponsor of the HKUST One Million Dollar Entrepreneurship Competition 2021.
 
The competition is a signature event of the Hong Kong University of Science and Technology (HKUST) aiming to provide a platform for the University and surrounding community members an integrative learning experience to create and evaluate new business and to prepare students to start their future career in entrepreneurship. Since 2020, the University has expanded the competition in 7 different regions including Zhongshan and Foshan in addition to Hong Kong, Beijing, Guangzhou, Macau and Shenzhen.
 
Our Managing Director, Mr. Vincent Pang was pleased to be invited to host the competition webinar “Startup Valuation: What you need to know?” on 9 Apr. Vincent shared the key elements for early-stage companies to attract investors relating to the consideration of Venture Capital and the competitive advantages of the business, introduced the fundamentals of business valuations for startup with case studies and covered the key issues for term sheet negotiation.
 
<img src="../../../../../uploads/1_40d3b2f251.png" width="700" />
 
<img src="../../../../../uploads/2_2a4f5e8e35.png" width="700" />
 
<img src="../../../../../uploads/3_5bec41815b.JPG" width="700" />

banner1

As the sponsor of the HKUST One Million Dollar Entrepreneurship Competition 2021 and the speaker of the webinar — “Startup Valuation: What you need to know?”

Congratulations to Smart Share Global Ltd. (stock code: EM.US) on its successful listing on NASDAQ on 1 Apr 2021. With regard to this listing application, AVISTA Group is honored to be engaged in providing financial instruments valuation services (preferred shares, restricted stock units and warrants).
 
<img src="../../../../../uploads/SS_EN_7fa30c8021.JPG" width="700" />
 
<img src="../../../../../uploads/SS_2_48f218b07b.png" width="700" />
 
<img src="../../../../../uploads/SS_3_b158e195ac.png" width="700" />

Congratulations to Smart Share Global Ltd. (Stock Code: EM.US) on its Successful Listing 

Our Managing Director, Mr. Vincent Pang was pleased to be invited by the CFA Society Hong Kong to speak on the “High-Risk, High-Reward? How to assess the value of a Biotech company?” webinar.
 
The webinar received around 180 registrations, gathering fellow CFAs that would like to better understand the valuation of biotechnology company under the surge of Biotech listings on HKEX due to the introduction of Chapter 18A of the Listing Rules in 2018.
 
Vincent introduced the attributes of biotechnology industry and its challenges to traditional valuation approaches, shared the valuation methods for biotechnology company with case studies, and highlighted the limitations of each method.
 
<img src="../../../../../uploads/cfa_1_f47a75cde2.jpg" width="700" />
 
<img src="../../../../../uploads/cfa_2_e5bf752cfc.png" width="700" />
 
<img src="../../../../../uploads/cfa_3_639af22631.JPG" width="700" />

As the speaker of the CFA Society Hong Kong’s webinar—"High-Risk, High-Reward? How to assess the value of a Biotech company?”

Congratulations to Connect Biopharma Holdings Ltd. (stock code: CNTB.US) on its successful listing on NASDAQ on 19 Mar 2021. With regard to this listing application, AVISTA Group is honored to be engaged in providing valuation services in relation to preferred shares financing and employee equity incentive plan.
 
<img src="../../../../../uploads/Connect_EN_434fb90f9f.JPG" width="700" />

Congratulations to Connect Biopharma Holdings Ltd. (Stock Code: CNTB.US) on its Successful Listing

Congratulations to Tuya Inc. (stock code: TUYA.US) on its successful listing on NYSE on 18 Mar 2021. With regard to this listing application, AVISTA Group is honored to be engaged in providing financial instruments valuation services.
 
<img src="../../../../../uploads/tuya_en_d2a617f915.JPG" width="700" />

Congratulations to Tuya Inc. (Stock Code: TUYA.US) on its Successful Listing

Our Managing Director, Mr. Vincent Pang recently hosted the webinar: “How to Prepare for Fundraising—Common Issues and Recommendations” under the SGS-AVISTA Business Enhancement Webinar Series.
 
Vincent covered the key issues for startup companies to take note of along the deal cycle, including decision process of investors, preparation for securing potential investors, introduction to startup valuation and term sheet, common issues of due diligence and also post-investment monitoring.
 
<img src="../../../../../uploads/s3_cbc0b78685.JPG" width="700" />
 
<img src="../../../../../uploads/s1_be1ddb55dc.png" width="700" />

SGS-AVISTA Business Enhancement Webinar Series: “How to Prepare for Fundraising—Common Issues and Recommendations” 

Congratulations to SciClone Pharmaceuticals (Holdings) Ltd. (stock code: 6600.HK) on its successful listing on the Main Board of the HKSE on 3 Mar 2021. With regard to this listing application, AVISTA Group is honored to be engaged in providing valuation services relating to equity incentive plan, financial assets, financial liabilities, total equity value and impairment test of intangible asset.
 
<img src="../../../../../uploads/sciclone_en_3e6b9594c9.JPG" width="700" />